Dalmia Bharat Sugar and Industries Limited
Valuation (95/100) does the heavy lifting; financial trend (7/100) is the drag.
Buy zoneSolvency riskDalmia Bharat Sugar and Industries Limited earns a Sell from StocksWizard, with a blended score of 40/100. On 12.5x trailing earnings it sits cheaper than the Consumer Defensive median of about 26.1x. The price is about 12% below its 52-week high of ₹400.9 and 35% above the low of ₹259.44. Financial health scores 33/100, in the grey band on the Altman Z-score, with a Piotroski F-score of 3/9. The average analyst target of ₹450 implies about 28% upside across 1 analysts. It clears 5 of 13 investability checks, with durability 37, valuation 90 and momentum 59 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹561.44. Low-confidence estimate — limited data.
Analyst views
1-year price
EOD · 2026-07-3152-week range
-12.47% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Sell40Piotroski F-score 3/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Fail: ROE above 15%: 7.3%
- Fail: Low debt (D/E < 0.5): 0.56x
- Fail: Positive free cash flow
- Fail: Revenue growth > 10%: -3%
- Fail: Earnings growing: -50%
- Fail: Net margin ≥ 10%: 6.5%
- Pass: Current ratio > 1.5: 1.58
- Pass: Below our fair value
- Pass: Margin of safety ≥ 20%
- Pass: Above 200-day average
- Pass: Above 50-day average
- No data: Positive 1-year return
- Fail: Altman Z in safe zone: Z 2.31
- Fail: Piotroski ≥ 7: 3/9
Quarterly results
Annual financials
Shareholding
- Promoter83.4%
- Institutions0.3%
- Public & other16.2%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Opportunities
- Trading in our value buy zone versus sector peers.
- Trades ~100% below our estimated fair value.
Bear case
Weaknesses
- Low return on equity (7.3%).
- Weak Piotroski score (3/9).
Threats
- Earnings contracting year on year.
About Dalmia Bharat Sugar and Industries Limited
Dalmia Bharat Sugar and Industries Limited operates sugar production facilities in India and internationally across three business segments: Sugar, Distillery, and Others. The company manufactures refined sugar, double sulphitation sugars, sulphur-free white crystal sugar, and natural brown sugar under its Dalmia Utsav brand, along with alcohol-based hand sanitizers.
Dalmia Bharat Sugar and Industries Limited — frequently asked questions
Is Dalmia Bharat Sugar and Industries Limited a buy, hold or sell?
StocksWizard currently rates Dalmia Bharat Sugar and Industries Limited (DALMIASUG) a Sell, based on a blended score of 40/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Dalmia Bharat Sugar and Industries Limited's fair value?
Our blended DCF and relative-valuation model estimates Dalmia Bharat Sugar and Industries Limited's fair value at about ₹701.8, versus a current price of ₹350.9 — roughly 100% upside. On that basis the stock looks undervalued by 100%.
Is Dalmia Bharat Sugar and Industries Limited financially healthy?
Dalmia Bharat Sugar and Industries Limited scores 33/100 on our financial-health model, placing it in the grey band on the Altman Z-score, with a Piotroski F-score of 3/9.
How has Dalmia Bharat Sugar and Industries Limited's share price performed?
Dalmia Bharat Sugar and Industries Limited is down 12% over three months, and last traded at ₹350.9. Past performance doesn't predict future returns.
More in Consumer Defensive
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.